EPIRUS Biopharma manufactures and commercialize biosimilar monoclonal antibodies.
Business Model:
Revenue: $1.4M
Employees: 51-200
Address: 699 Boylston St
City: Boston
State: MA
Zip: 02116
Country: US
EPIRUS Biopharma manufactures and commercialize biosimilar monoclonal antibodies.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/15/2014
Ticker Symbol:
EPRS
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2012 | Venture Round | 2 | $5M |
5AM Ventures Montreux Equity Partners 5AM Ventures Montreux Equity Partners |
4/2014 | Series B | 8 | $36M |
5AM Ventures Adage Capital Management Gibralt Capital Corporation Greenwoods Investment Livzon Mabpharm Montreux Equity Partners Mousse Partners TPG Biotech 5AM Ventures Adage Capital Management Gibralt Capital Corporation Greenwoods Investment Livzon Mabpharm Montreux Equity Partners Mousse Partners TPG Biotech |
1/2011 | Series A | $34M | 4/2012 | Venture Round | 2 | $8.1M |
5AM Ventures Montreux Equity Partners 5AM Ventures Montreux Equity Partners |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|